Sierra Oncology

Sierra Oncology is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with cancer. The company is focused on developing an emerging pipeline of next generation therapies that target the DNA Damage Response (DDR) network. The company's primary product candidate, SRA737, is an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is a key regulator of cell cycle progression and the DDR replication stress response. The company is also advancing SRA141, a selective and orally bioavailable small molecule inhibitor of cell division cycle 7 kinase undergoing preclinical development.
  • TickerSRRA
  • ISINUS82640U1079
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ValuEngine Rating and Forecast Report for SRRA

ResearchPool Subscriptions

Get the most out of your insights

Get in touch